Ajanta Pharma Limited | AJANTPHARM | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 560 | 931 | 952 | 2,053 | 2,096 |
Short-term investment |
| 1,816 | 1,824 | 647 | 671 | 1,757 |
Accounts receivables |
| 3,218 | 4,920 | 4,595 | 7,753 | 7,384 |
Inventories |
| 2,110 | 3,506 | 4,357 | 4,957 | 7,665 |
Deferred income taxes |
| 112 | 0 | 0 | 0 | 0 |
Other current assets |
| 649 | 1,055 | 1,261 | 983 | 1,374 |
Total current assets |
| 8,466 | 12,236 | 11,812 | 16,417 | 20,276 |
Gross property plant... |
| 5,832 | 10,452 | 14,332 | 13,602 | 14,292 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 5,832 | 10,452 | 14,332 | 13,602 | 14,292 |
Work in Progress |
| 3,380 | 613 | 0 | 1,319 | 1,082 |
Miscellaneous Investment |
| 0 | 76 | 0 | 373 | 253 |
Deferred income taxes |
| 245 | 454 | 318 | 392 | 715 |
Intangible assets |
| 72 | 75 | 67 | 117 | 108 |
Goodwill |
| 0 | 0 | 0 | 0 | 0 |
Other long-term assets |
| 232 | 580 | 433 | 967 | 1,061 |
Total non-current assets |
| 9,761 | 12,250 | 15,150 | 16,770 | 17,511 |
Total assets |
| 18,227 | 24,486 | 26,962 | 33,187 | 37,787 |
Short-term debt |
| 55 | 0 | 353 | 429 | 0 |
Accounts Payable... |
| 1,396 | 2,496 | 2,252 | 3,623 | 3,739 |
Provisions |
| 128 | 288 | 0 | 92 | 117 |
Taxes Payable |
| 0 | 37 | 0 | 117 | 489 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 0 | 173 | 115 |
Other current liabilities |
| 655 | 640 | 1,172 | 1,628 | 2,026 |
Total current liabilities |
| 2,234 | 3,461 | 3,776 | 6,062 | 6,486 |
Long-term debt |
| 10 | 10 | 7 | 7 | 16 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 273 | 470 | 589 | 812 | 922 |
Provisions |
| 32 | 132 | 0 | 157 | 179 |
Capital Leases |
| 0 | 0 | 0 | 120 | 182 |
Other longterm liabilities |
| 0.9 | 0 | 138 | 41 | 46 |
Total non-current liabilities |
| 316 | 612 | 733 | 1,137 | 1,345 |
Total liabilities |
| 2,550 | 4,072 | 4,510 | 7,198 | 7,831 |
Share Capital |
| 177 | 177 | 175 | 175 | 174 |
Share premium |
| 0 | 0 | 23 | 0 | 0 |
Retained earnings |
| 15,500 | 20,237 | 12,695 | 25,813 | 29,782 |
Accumulated other equity |
| 0 | 0 | 9,559 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 | 0 |
Total Equity |
| 15,677 | 20,414 | 22,452 | 25,989 | 29,956 |
Total Liabilities and Equity |
| 18,227 | 24,486 | 26,962 | 33,187 | 37,787 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |